Rob Louie, RPh, MBA

“RemedyOne’s talented team has decades of experience in the health care delivery system and is committed to fixing inefficiencies in the healthcare system. We take the time to listen to our client’s unique situations in order to provide innovative solutions tailored to the individual needs of our clients.”

New Developments in Macular Degeneration/Diabetic Eye Disease

Visual impairment can be a major health issue for older adults, ranging from a minor inconvenience to vision loss significantly impacting quality of life.  Age-related macular degeneration (AMD) is a neurodegenerative disease of the retina and would fall into the latter category. It’s the leading cause of irreversible vision loss among the elderly. In 2016, …

New Developments in Macular Degeneration/Diabetic Eye Disease Read More »

Biogen’s New Alzheimer’s Drug is a Compound of Hope and Controversy

For the first time in 18 years, the FDA has approved a drug to treat patients with Alzheimer’s disease. It’s great news for the millions of Americans, and their family members, who are fighting this terrible disease. But all the news was not great. The approval did not come without controversy. The fact that three …

Biogen’s New Alzheimer’s Drug is a Compound of Hope and Controversy Read More »

Digital Health Trends: Digital Therapeutics

Defining the Digital Health Landscape Digital health has been a trending topic for several years now. Using technology to improve health and wellness is a broad and growing sector. Smartwatches or trackers that can track steps, heart rates, and other health markers are seen everywhere, but digital health goes beyond wearable devices that promote general …

Digital Health Trends: Digital Therapeutics Read More »

The Most Favored Nation Model and Interim Final Rule – What is this?

The rising costs of physician-administered drugs covered under Medicare Part B is one of the largest drivers of Medicare spend which have risen approximately 11.5% annually since 2015, with a total spend of approximately $30 billion in 20191. Lowering drug cost is essential to maintain Medicare for our aging population. Lowering drug prices has been …

The Most Favored Nation Model and Interim Final Rule – What is this? Read More »